Companies/Acro Biomedical Co., Ltd.

Company profile

Acro Biomedical Co., Ltd.

OTC: ACBM · Healthcare · Biotechnology

PublicHQ Fishers, IN · HamiltonCIK 0001622996Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

16D

FH 4DQ 32GM 21SS 19

v0.1 · 65/100 weight · provisional

↑ disclosure history, growth stability · ↓ workforce scale, 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$101.1k

Employees

Market cap

$1.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02025

Net income-$101.1k-$101.1k2025

Operating income-$154.0k-$154.0k2025

Total assets$14.1k$14.1k2025

Liabilities$326.9k$326.9k2024

Equity-$387.0k-$387.0k2025

Revenue trend

FY2019 – FY2025 · USD

$1.4M

FY19

$193.5k

FY20

$688.0k

FY20

$1.2M

FY21

$658.5k

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Acro Biomedical Co., Ltd. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

CannaPharmaRX, Inc.38D SOHM, Inc.61C Meridian Holdings, Inc.——International Stem Cell Corporation57C

Neighbors

Hamilton →

CNO Financial Group, Inc.$4.5B67B OPENLANE, Inc.$1.9B64C Merchants Bancorp——MBX Biosciences, Inc. Common Stock——First Internet Bancorp$11.5M30D American Resources Corporation$051D

Key facts

CEOYu-Ting Su

SectorHealthcare

IndustryBiotechnology

HeadquartersFishers, IN

ExchangeOTC: ACBM

Employees1

IPO date2021-01-08

Latest filings

10-Q2026-05-05 10-K2026-02-11 8-K2026-01-08 10-Q2025-11-10 8-K2025-08-14 10-Q2025-08-05 10-K2025-07-24 10-Q2025-07-24

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.